Jie Ren1, Bin Liu1, Li-Li Zhang1, Hong-Yu Li1, Fan Zhang1, Shuang Li1, Li-Rong Zhao2. 1. Departments of Echocardiography (J.R., L.-L.Z., H.-Y.L., F.Z., S.L., L.-R.Z.) and Science and Education (B.L.), First Hospital of Jilin University, Changchun, China. 2. Departments of Echocardiography (J.R., L.-L.Z., H.-Y.L., F.Z., S.L., L.-R.Z.) and Science and Education (B.L.), First Hospital of Jilin University, Changchun, China. liubinzhlr@aliyun.com.
Abstract
OBJECTIVES: The purpose of this study was to evaluate whether a nodule with a taller-than-wide shape (ie, an anteroposterior diameter that is longer than the transverse diameter on a transverse or longitudinal plane [anteroposterior-to-transverse ratio] >1) is a good predictor of papillary thyroid carcinoma (PTC) according to nodule size. METHODS: We retrospectively examined 207 thyroid nodules in our hospital from September 2011 to February 2013. Nodules were divided into groups by size: small (≤0.5 cm; group A), medium (0.5-1 cm; group B), and large (>1 cm; group C). Sonographic features were defined as an anteroposterior-to-transverse ratio greater than 1, microcalcifications, blurred margins, and hypoechogenicity. RESULTS: An anteroposterior-to-transverse ratio greater than 1 was the most accurate sonographic feature for predicting PTC in small nodules, with high sensitivity (81.4%) and specificity (96.8%), but it was not accurate in large nodules (>1 cm). Microcalcifications showed higher sensitivity (P< .05) in large nodules (60.0%) than in small ones (27.9%). Hypoechogenicity and blurred margins showed high sensitivity (95.3% and 97.7%, respectively) but low specificity (19.4% and 29.9%) for diagnosis of PTC in small thyroid nodules. An anteroposterior-to-transverse ratio greater than 1 in conjunction with another sonographic feature achieved the highest diagnostic accuracy in small nodules. CONCLUSIONS: The predictive values of sonographic features depend on nodule size. An anteroposterior-to-transverse ratio greater than 1, especially in conjunction with another sonographic risk factor, showed superior performance for PTC diagnosis in small nodules.
OBJECTIVES: The purpose of this study was to evaluate whether a nodule with a taller-than-wide shape (ie, an anteroposterior diameter that is longer than the transverse diameter on a transverse or longitudinal plane [anteroposterior-to-transverse ratio] >1) is a good predictor of papillary thyroid carcinoma (PTC) according to nodule size. METHODS: We retrospectively examined 207 thyroid nodules in our hospital from September 2011 to February 2013. Nodules were divided into groups by size: small (≤0.5 cm; group A), medium (0.5-1 cm; group B), and large (>1 cm; group C). Sonographic features were defined as an anteroposterior-to-transverse ratio greater than 1, microcalcifications, blurred margins, and hypoechogenicity. RESULTS: An anteroposterior-to-transverse ratio greater than 1 was the most accurate sonographic feature for predicting PTC in small nodules, with high sensitivity (81.4%) and specificity (96.8%), but it was not accurate in large nodules (>1 cm). Microcalcifications showed higher sensitivity (P< .05) in large nodules (60.0%) than in small ones (27.9%). Hypoechogenicity and blurred margins showed high sensitivity (95.3% and 97.7%, respectively) but low specificity (19.4% and 29.9%) for diagnosis of PTC in small thyroid nodules. An anteroposterior-to-transverse ratio greater than 1 in conjunction with another sonographic feature achieved the highest diagnostic accuracy in small nodules. CONCLUSIONS: The predictive values of sonographic features depend on nodule size. An anteroposterior-to-transverse ratio greater than 1, especially in conjunction with another sonographic risk factor, showed superior performance for PTC diagnosis in small nodules.
Authors: Theodora Pappa; Sara Ahmadi; Athanasios Bikas; Sally Hwang; Alexandra Coleman; Isabel Lobon; Pingping Xiang; Matthew Kim; Ellen Marqusee; Danielle M Richman; Sara M Durfee; Elizabeth H Asch; Carol B Benson; Mary C Frates; Iñigo Landa; Erik K Alexander Journal: J Clin Endocrinol Metab Date: 2022-06-16 Impact factor: 6.134
Authors: A Aslan; S Sancak; M Aslan; E Ayaz; I Inan; S S Ozkanli; O Alimoğlu; A Yıkılmaz Journal: Acta Endocrinol (Buchar) Date: 2018 Jan-Mar Impact factor: 0.877
Authors: Arunnit Boonrod; Zeynettin Akkus; M Regina Castro; Atefeh Zeinodini; Kenneth Philbrick; Marius Stan; Dana Erickson; Bradley Erickson Journal: Asian Pac J Cancer Prev Date: 2021-08-01